Double-blind treatment study of shigellosis comparing ampicillin, sulfadiazine, and placebo.
D000293:Adolescent; D000667:Ampicillin / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D002175:Candida / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004405:Dysentery, Bacillary / Q000188:drug therapy* / Q000382:microbiology; D005260:Female; D006801:Humans; D007223:Infant; D007958:Leukocyte Count; D008297:Male; D010403:Penicillin Resistance; D010919:Placebos; D012760:Shigella / Q000302:isolation & purification; D012762:Shigella dysenteriae / Q000302:isolation & purification; D012764:Shigella sonnei / Q000302:isolation & purification; D012964:Sodium / Q000097:blood; D013411:Sulfadiazine / Q000627:therapeutic use*
D010919:Placebos; D013411:Sulfadiazine; D000667:Ampicillin; D012964:Sodium; D001219:Aspartate Aminotransferases